TYRA
Tyra Biosciences, Inc. · Healthcare · Market cap $1.2B
Insiders bought $20K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Sep 11, 2026
Insider Buying
$20K
reported purchases (SEC code P)
Insider Selling
$10.6M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Sep 17, 2026
Verjee Rehan
Tyra Biosciences, Inc. (TYRA) has 19 SEC Form 4 filings (28 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Sep 17, 2026.
Inside the rolling window, 4 insiders at Tyra Biosciences, Inc. reported 1 open-market purchase totaling $20K and 11 open-market sales totaling $10.6M. The most active filer is Chief Discovery Officer Bensen Daniel with 8 filings. Insiders have net sold $509K over the trailing 6 months. The most recent open-market filing is a purchase of 971.894 shares by Director Verjee Rehan, dated Sep 9, 2026, worth $20K.
- Industry:Biotechnology
- CEO:Todd Harris
- Employees:87
- HQ:Carlsbad, CA, US
- IPO:2021-09-15
| Source | |||||||
|---|---|---|---|---|---|---|---|
Verjee RehanFirst filing | Director | Purchase | 971.894 | $20K | Sep 11 | -6.5% | SEC ↗ |
KAPLAN GILLAFirst filing | Director | Sale | 14,295 | $529K | Mar 27 | -43.2% | SEC ↗ |
| Chief Discovery Officer | Sale | 8,000 | $263K | Feb 13 | -26.4% | SEC ↗ | |
| Chief Discovery Officer | Sale | 8,000 | $228K | Jan 20 | -30.2% | SEC ↗ | |
| Director | Sale | 10,000 | $250K | Dec 19 | -19.2% | SEC ↗ | |
| Chief Discovery Officer | Sale | 8,000 | $181K | Dec 16 | -10.3% | SEC ↗ | |
MORE ROBERT JFirst filing | Director | Sale | 246,871 | $5.0M | Nov 25 | -5.9% | SEC ↗ |
| Chief Operating Officer | Sale | 75,633 | $1.2M | Nov 19 | +23.9% | SEC ↗ | |
| Chief Operating Officer | Sale | 49,956 | $815K | Nov 19 | — | SEC ↗ | |
Bensen DanielFirst filing | Chief Operating Officer | Sale | 1,111 | $18K | Nov 17 | — | SEC ↗ |
Bensen DanielFirst filing | Chief Operating Officer | Sale | 110,228 | $1.8M | Nov 17 | — | SEC ↗ |
Bensen DanielFirst filing | Chief Operating Officer | Sale | 20,072 | $325K | Nov 17 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does TYRA have?
Tyra Biosciences, Inc. (TYRA) has 19 SEC Form 4 filings (28 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Sep 17, 2026.
When was the most recent SEC Form 4 filing for TYRA?
The most recent Form 4 filing for TYRA on Tracefour is dated Sep 17, 2026.
Who is the most active insider at TYRA?
The most active SEC Form 4 filer at TYRA in the rolling window is Chief Discovery Officer Bensen Daniel, with 8 filings.
What is the net insider flow at TYRA over the last 6 months?
Over the trailing 180 days, insiders at TYRA have net sold $509K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TYRA in the current window?
Inside the rolling window, insiders at TYRA bought $20K and sold $10.6M based on SEC Form 4 filings.
Can I get alerts for TYRA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Tyra Biosciences, Inc. (TYRA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Tyra Biosciences, Inc. is in the Healthcare sector.